Sort
48,018 grants matching “immunotherapy”
Immunotherapy for Ocular Surface Diseases
$1,952,701Sandeep Jain · University Of Illinois At Chicago · R24 · FY2023 · EY
Mathematical Oncology Systems Analysis Imaging Center (MOSAIC)
$1,951,992Kristin R Swanson · Mayo Clinic Arizona · U54 · FY2024 · CA
Identifying Metabolic Vulnerabilities in Lung Cancer
$1,951,918Elsa R Flores · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2024 · CA
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
$1,951,470Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Biology and Therapy of High Risk Neuroblastoma
$1,950,665Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2009 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,950,196University Of Washington · U01 · FY2001 · AI
Colorado Head and Neck Cancer SPORE
$1,950,049Antonio Jimeno · University Of Colorado Denver · P50 · FY2025 · CA
The UCLA Center for In Vivo Imaging in Cancer Biology
$1,947,512Harvey R. Herschman · University Of California Los Angeles · P50 · FY2006 · CA
SPORE in Skin Cancer
$1,946,960Brigham And Women'S Hospital · P50 · FY2005 · CA
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
$1,943,996Luc Teyton · Scripps Research Institute, The · P01 · FY2024 · AI
The University of Texas MD Anderson Cancer Center SPORE in Melanoma
$1,943,851Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
MOLECULAR MECHANISMS OF RESPONSE AND RESISTANCE TO IMMUNOTHERAPY IN MESOTHELIOMA
$1,943,806The Johns Hopkins University · · FY2020 · Defense Health Agency
Heterodimeric IL-15 in Cancer Immunotherapy
$1,943,565George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Biology and Transplantation of the Hematopoietic Stem Cell
$1,940,892John E Wagner · University Of Minnesota · P01 · FY2015 · CA
Towards Eradication: Reducing Proviral HIV DNA with Interferon-α Immunotherapy
$1,939,835Luis J. Montaner · Wistar Institute · U01 · FY2015 · AI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,939,404Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2013 · CA
Biology and Therapy of High Risk Neuroblastoma
$1,938,669Children'S Hospital Los Angeles · P01 · FY2005 · CA
NK cells, their receptors and unrelated donor transplant
$1,937,144Jeffrey S Miller · University Of Minnesota · P01 · FY2012 · CA
Overcoming the Tumor Microenvironment
$1,936,000Wendell A Lim · University Of California, San Francisco · U54 · FY2019 · CA
Molecular Mechanisms of Blood Cell Transfusion
$1,935,701Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2013 · HL
ADULT AIDS CLINICAL TRIALS UNIT
$1,935,539Washington University · U01 · FY2002 · AI
Cancer Immune Monitoring and Analysis Center
$1,934,873Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · U24 · FY2025 · CA
Cell Production Core Facility
$1,933,442Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Surgery Branch Cell Prep Core
$1,933,442Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Enhancing T Cell Therapy of Cancer
$1,932,287Helen E Heslop · Baylor College Of Medicine · P01 · FY2013 · CA